PTGX – protagonist therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Protagonist Therapeutics Reports Granting of Inducement Awards [Yahoo! Finance]
Protagonist Therapeutics (PTGX) was given a new $121.00 price target by Truist Financial Corporation.
Is Protagonist Therapeutics (PTGX) Still Attractive After A 133% One-Year Share Price Surge [Yahoo! Finance]
Protagonist Announces Presentation of One-Year Phase 3 Data for ICOTYDE(TM) in Moderate-to-Severe Plaque Psoriasis at the 2026 American Academy of Dermatology (AAD) Annual Meeting [Yahoo! Finance]
Do Protagonist Therapeutics' (PTGX) Derisked Drugs Have Blockbuster Potential? [Yahoo! Finance]
Form 4 Protagonist Therapeutics For: Mar 26 Filed by: MOLINA ARTURO MD
Form 4 Protagonist Therapeutics For: Mar 26 Filed by: SELICK HAROLD E
Form 4 Protagonist Therapeutics For: Mar 26 Filed by: Ali Asif
Form SCHEDULE 13G/A Protagonist Therapeutics Filed by: VANGUARD GROUP INC
Form 144 Protagonist Therapeutics Filed by: SELICK HAROLD E
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.